Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CHroniSense National Early Warning Score Study

NCT03448861 is registered in ClinicalTrials.gov with BlueWind Medical as lead sponsor.

NCT NCT03448861
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03448861 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CHroniSense National Early Warning Score Study
Lead sponsor
BlueWind Medical
Phase
Not applicable
Overall status
Unknown status
Start date
June 30, 2018
Completion date
November 30, 2019
Enrollment
250 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

clinical assessment